Regulatable Fusogenic HSV-1 for Selective Solid Tumor Killing

The patent applies local quality by making the virus replication property-specific to different cell types. The oncolytic virus is engineered to replicate selectively in tumor cells through conditional replication control mechanisms, while normal cells remain resistant to viral replication. This is achieved by incorporating tumor-specific promoters and regulatory elements that enable viral gene expression only in the pathological environment of tumor cells, thereby destroying tumor cells without harming normal cells.

The patent utilizes parameter changes by controlling viral replication through environmental or cellular parameter differences. The oncolytic virus is designed to sense and respond to specific parameters present in tumor cells (such as elevated temperature, altered pH, specific receptor expression, or cellular stress markers) and activate replication only when these parameters indicate a tumor cell environment. This parameter-based control allows the virus to differentiate between tumor and normal cells, achieving selective tumor destruction while sparing healthy tissue.

The patent applies dynamics by implementing a dynamic control system for viral replication that can adapt to different cellular environments. Instead of static gene deletions that permanently reduce replication capability, the invention uses inducible or conditionally active genetic elements that dynamically regulate viral replication based on cellular context. The virus contains genes that are activated or deactivated in response to tumor-specific signals, allowing maximum oncolytic activity in tumor cells while maintaining safety in normal cells through dynamic on/off switching of replication functions.

The patent uses intermediary mechanisms by introducing mediator molecules or proteins that control viral replication. These intermediaries act as molecular switches or regulators that are present in tumor cells but absent or inactive in normal cells. The oncolytic virus incorporates genetic elements that require these intermediary factors for efficient replication, creating a dependency that enables selective tumor cell destruction. The intermediaries serve as the link between the virus and the tumor-specific environment, allowing the virus to distinguish between cell types without permanent genetic deletions.